Results 161 to 170 of about 28,989 (238)

Rationale and Design of CARDIO-TTRansform, a Phase 3 Trial of Eplontersen in Transthyretin Amyloid Cardiomyopathy. [PDF]

open access: yesCirc Heart Fail
Masri A   +20 more
europepmc   +1 more source

Amyloid fibril polymorphism in the heart and liver of a patient with polyneuropathic ATTRv-V122Δ amyloidosis. [PDF]

open access: yesCommun Biol
Ahmed Y   +16 more
europepmc   +1 more source

Efficacy and Safety of Acoramidis in Japanese Adults With Symptomatic Transthyretin Amyloid Cardiomyopathy. [PDF]

open access: yesCirc Rep
Endo J   +17 more
europepmc   +1 more source

Fully Automated vs. Human Echocardiogram Interpretation in Transthyretin Amyloid Cardiomyopathy: The SCAN-MP Study. [PDF]

open access: yesJ Am Soc Echocardiogr
McMenamin KJ   +13 more
europepmc   +1 more source

Therapy of Transthyretin Cardiomyopathy

open access: yesJournal of the American College of Cardiology, 2019
openaire   +2 more sources

Correlation between neuropathy severity and neurofilament light chain levels in Brazilian patients with hereditary transthyretin amyloidosis. [PDF]

open access: yesSci Rep
Ferreira P   +6 more
europepmc   +1 more source

Don't raise your white flag facing a sea of red ones: when cardiac amyloidosis mimics hypertrophic cardiomyopathy. [PDF]

open access: yesESC Heart Fail
Grilli G   +11 more
europepmc   +1 more source

Best Practices and Key Barriers for Amyloidosis Patient Care at US Specialized Amyloidosis Centers: An Analysis by ARC-ASPIRE. [PDF]

open access: yesClin Med Insights Cardiol
Nativi-Nicolau J   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy